Use of heparin upon reoperation in a pediatric patient with heparin-induced thrombocytopenia after disappearance of antibodies.
Schreiber
Christian
C
Deutsches Herzzentrum München, Klinik für Herz-Gefässchirurgie an der Technischen Universität München, Lazarettstrasse 36, 80636, München, Germany. schreiber@dhm.mhn.de
Dietrich
W
W
Braun
S
S
Kostolny
M
M
Eicken
A
A
Lange
R
R
D000906:Antibodies / Q000097:blood* / Q000187:drug effects; D000925:Anticoagulants / Q000009:adverse effects*; D007611:Aprotinin / Q000627:therapeutic use; D006348:Cardiac Surgical Procedures; D002315:Cardiopulmonary Bypass; D002648:Child; D004359:Drug Therapy, Combination; D019918:Heart Valve Prosthesis Implantation; D006490:Hemostatics / Q000627:therapeutic use; D006493:Heparin / Q000009:adverse effects*; D006629:Hirudins; D006801:Humans; D008297:Male; D008943:Mitral Valve / Q000601:surgery; D010644:Phenprocoumon / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D010978:Platelet Factor 4 / Q000187:drug effects / Q000378:metabolism; D011994:Recombinant Proteins / Q000627:therapeutic use; D012086:Reoperation; D013921:Thrombocytopenia / Q000097:blood* / Q000139:chemically induced* / Q000188:drug therapy; D000077466:Tirofiban; D014443:Tyrosine / Q000031:analogs & derivatives / Q000627:therapeutic use; D014694:Ventricular Outflow Obstruction / Q000601:surgery
D000906:Antibodies; D000925:Anticoagulants; D006490:Hemostatics; D006629:Hirudins; D010975:Platelet Aggregation Inhibitors; D011994:Recombinant Proteins; D010978:Platelet Factor 4; D014443:Tyrosine; D006493:Heparin; D007611:Aprotinin; D000077466:Tirofiban; D010644:Phenprocoumon; C083544:lepirudin